Article
24 Nov 2023
FDA Warning Letters Explained: An Opportunity, Not A Threat
AUTHORS CONTENT
Article
31 Aug 2023
FDA Issues Second Warning Letter Of 2023 Over Potentially Misleading Efficacy Claims Regarding Inhaler
Article
18 Aug 2023
FDA Issues Draft Guidance On Pre-market Submissions For Patient-Matched Guides To Orthopedic Implants
Article
17 Aug 2023
FDA Draft Guidance Recommends Info To Include In Patient-Matched Guides To Orthopedic Implants
Article
11 Aug 2023
FDA Issues New Nitrosamine Impurities Guidance
Article
11 Aug 2023
Nitrosamine Impurities FDA Guidance
Article
12 Jul 2023
Latest FDA Guidance Includes Minor Procedural Updates To Q-Subs For Medical Devices
Article
16 Jun 2023
FDA Seeks Input From Life Sciences Industry On Controlling Nitrosamine Impurities
Article
11 Apr 2023
CMS Issues Initial Guidance On Medicare Drug Price Negotiation Program
Article
29 Jun 2022
FTC Publishes Proposed Changes To Guides Concerning The Use Of Endorsements And Testimonials In Advertising
Article
03 May 2022
FDA Issues Guidance On Compounding Animal Drugs From Bulk Drug Substances
Article
27 Apr 2022
FDA Issues Guidance On Compounding Animal Drugs From Bulk Drug Substances
Article
18 Mar 2022
FDA Final Guidance On Initiating Voluntary Recalls: Be "Recall Ready"
Article
14 Feb 2022
District Court Of Delaware Rules For Generic Pharma's Use Of Skinny Label, But Permits Induced Infringement Suit To Proceed Against Insurer
Article
29 Sep 2021
FDA Issues Final Rule On "Intended Use"
Article
31 Aug 2021
Federal Circuit's Rehearing Decision Confirms Induced Infringement Even When Skinny Label Was Used
Article
27 Jul 2021
FDA Issues Final Guidance On Form And Content Of Unique Device Identifier Labeling System
Article
17 Dec 2020
FDA's Additional Draft Guidance On Biosimilarity And Interchangeability To Seek Comments And Suggestions By January 19, 2021
Article
20 Nov 2020
Federal Circuit Holds That, For Venue Purposes, Patent Infringement Occurs Only In Districts Where Actions Related To ANDA Submissions Occur
Article
04 Nov 2020
Federal Circuit Finds Induced Infringement Of Drug Patent, Even When Skinny Label Was Used